US Expansion Arrayjet recently opened its first US Printing Suite in Bend, Oregon in collaboration with Grace Bio Labs, signaling a strategic move into North American markets and potential for increased demand from pharma, diagnostics, and life science customers.

High Throughput Focus The company’s fast, high-density inkjet microarray printing capabilities position it well for customers needing rapid screening and large-scale assays, offering a compelling value proposition for pharma and CROs pursuing time-to-result advantages.

Partnership Driven Customer relationships drive innovation, with ongoing collaborations such as Immunome and Chemspace, suggesting opportunities for co-development, bespoke assay services, and expanded printing with internal controls and data normalisation enhancements.

Regulatory & Quality Operates from an ISO 13485:2016 compliant facility, emphasizing quality and regulatory readiness, which can be leveraged to target medical device and diagnostic customers requiring validated manufacturing and documentation.

Portfolio Synergy Recent product launches like Mercury and breadth of instruments plus an expanding services model enable cross-sell to existing life science customers seeking ultra-low-volume dispensing, printing versatility, and end-to-end printing solutions.